Proficio Capital Partners LLC Sage Therapeutics, Inc. Transaction History

Proficio Capital Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$140.29 - $189.96 $12,906 - $17,476	-92 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$157.85 - $183.09 $2,999 - $3,478	19 Added 26.03%	92 $17,000
Q1 2019 May 13, 2019	BUY	$89.33 - $163.65 $3,037 - $5,564	34 Added 87.18%	73 $12,000
Q4 2018 Feb 08, 2019	BUY	$81.94 - $139.71 $1,720 - $2,933	21 Added 116.67%	39 $4,000
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $552 - $676	4 Added 28.57%	18 $3,000
Q2 2018 Aug 10, 2018	BUY	$140.36 - $175.76 $1,403 - $1,757	10 Added 250.0%	14 $2,000
Q4 2017 Feb 09, 2018	BUY	$60.72 - $167.34 $242 - $669	4	4 $1,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.